CLOV · Clover Health Investments Corp
United States · RS rating 96 · As of 2026-10-14
| Price | 4.79 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 84 / 84 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 54 / 56 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +150.0% |
| Sales growth Q/Q | -1.8% |
| Distance from 52-week high | +11.5% |
| Market cap (USD) | $1.3B |